Advances in diagnostic testing for Alzheimer disease.

Suzanne E. Schindler, Jonathan McConathy, Beau M. Ances, Marc I. Diamond

Research output: Contribution to journalArticle

5 Scopus citations


The diagnosis of Alzheimer disease (AD) dementia is based primarily on the clinical history and examination, but advances in understanding the pathophysiology of AD have led to new diagnostic methods. When used appropriately, the tests can provide strong positive or negative evidence AD dementia. This article described which patients may benefit from additional testing using Cerebrospinal Fluid (CSF) biomarkers, amyloid imaging, quantitative structural magnetic resonance imaging (MRI), and fluoro-deoxyglucose positron emission tomography (FDG-PET).

Original languageEnglish (US)
Pages (from-to)401-405
Number of pages5
JournalMissouri Medicine
Issue number5
Publication statusPublished - Sep 2013


ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schindler, S. E., McConathy, J., Ances, B. M., & Diamond, M. I. (2013). Advances in diagnostic testing for Alzheimer disease. Missouri Medicine, 110(5), 401-405.